Cellebrite DI (CLBT) Gains from Investment Securities (2021 - 2024)

Cellebrite DI's Gains from Investment Securities history runs 4 years deep, the most recent figure standing at -$62.4 million for Q4 2024.

• On a quarterly basis, Gains from Investment Securities fell 737.58% year-over-year to -$62.4 million in Q4 2024; TTM through Dec 2024 was $110.7 million, a 213.19% increase from a year earlier, with the FY2024 full-year figure at $110.7 million, up 224.51% from the prior year.
• Gains from Investment Securities eased to -$62.4 million in Q4 2024 per CLBT's latest filing, from $120.0 million in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $120.0 million in Q3 2024 and bottomed at -$62.4 million in Q4 2024.
• The 4-year median for Gains from Investment Securities is $2.8 million (2021), against an average of $7.0 million.
• Biggest YoY gain for Gains from Investment Securities was 5742.65% in 2024; the steepest drop was 737.58% in 2024.
• Year by year, Gains from Investment Securities stood at -$15.5 million in 2021, then jumped by 102.42% to $375000.0 in 2022, then jumped by 2509.33% to $9.8 million in 2023, then tumbled by 737.58% to -$62.4 million in 2024.
• Per Business Quant, the three latest CLBT Gains from Investment Securities figures stand at -$62.4 million (Q4 2024), $120.0 million (Q3 2024), and $12.7 million (Q2 2024).